Upper GI unit, Birmingham Heartlands Hospital, University Hospital Birmingham NHS Foundation Trust, Bordesley Green East, Birmingham, West Midlands, B9 5SS, UK.
Healthier Weight, Birmingham, UK.
Obes Surg. 2022 Jul;32(7):1-13. doi: 10.1007/s11695-022-06067-z. Epub 2022 May 5.
Age ≥ 65 years is regarded as a relative contraindication for bariatric surgery. Advanced age is also a recognised risk factor for adverse outcomes with Coronavirus Disease-2019 (COVID-19) which continues to wreak havoc on global populations. This study aimed to assess the safety of bariatric surgery (BS) in this particular age group during the COVID-19 pandemic in comparison with the younger cohort.
We conducted a prospective international study of patients who underwent BS between 1/05/2020 and 31/10/2020. Patients were divided into two groups - patients ≥ 65-years-old (Group I) and patients < 65-years-old (Group II). The two groups were compared for 30-day morbidity and mortality.
There were 149 patients in Group 1 and 6923 patients in Group II. The mean age, preoperative weight, and BMI were 67.6 ± 2.5 years, 119.5 ± 24.5 kg, and 43 ± 7 in Group I and 39.8 ± 11.3 years, 117.7±20.4 kg, and 43.7 ± 7 in Group II, respectively. Approximately, 95% of patients in Group 1 had at least one co-morbidity compared to 68% of patients in Group 2 (p = < 0.001). The 30-day morbidity was significantly higher in Group I (11.4%) compared to Group II (6.6%) (p = 0.022). However, the 30-day mortality and COVID-19 infection rates were not significantly different between the two groups.
Bariatric surgery during the COVID-19 pandemic is associated with a higher complication rate in those ≥ 65 years of age compared to those < 65 years old. However, the mortality and postoperative COVID-19 infection rates are not significantly different between the two groups.
年龄≥65 岁被认为是减肥手术的相对禁忌症。随着 2019 年冠状病毒病（COVID-19）继续在全球范围内肆虐，高龄也是 COVID-19 不良结局的公认危险因素。本研究旨在评估在 COVID-19 大流行期间，与年轻患者相比，这一年龄组接受减肥手术（BS）的安全性。
我们进行了一项前瞻性国际研究，纳入了 2020 年 5 月 1 日至 10 月 31 日期间接受 BS 的患者。患者分为两组：年龄≥65 岁（I 组）和年龄<65 岁（II 组）。比较两组患者的 30 天发病率和死亡率。
I 组有 149 例患者，II 组有 6923 例患者。I 组患者的平均年龄、术前体重和 BMI 分别为 67.6±2.5 岁、119.5±24.5kg 和 43±7，II 组患者的平均年龄、术前体重和 BMI 分别为 39.8±11.3 岁、117.7±20.4kg 和 43.7±7。I 组约 95%的患者至少有一种合并症，而 II 组只有 68%的患者（p<0.001）。I 组的 30 天发病率（11.4%）明显高于 II 组（6.6%）（p=0.022）。然而，两组间 30 天死亡率和 COVID-19 感染率无显著差异。
与年龄<65 岁的患者相比，COVID-19 大流行期间，年龄≥65 岁的患者接受减肥手术与更高的并发症发生率相关。然而，两组间死亡率和术后 COVID-19 感染率无显著差异。
